Repros Therapeutics, Inc. (RPRX) Posts Narrower than Expected Q3 Loss

November 10, 2011 9:26 AM EST
Get Alerts RPRX Hot Sheet
Price: $58.18 -0.6%

Financial Fact:
Total expenses: 4.18M

Today's EPS Names:
UBAB, LOAN, FITB, More
Join SI Premium – FREE
Repros Therapeutics, Inc. (NASDAQ: RPRX) reported Q3 loss of ($0.32), $0.03 better than the analyst estimate of ($0.35).


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings